🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
562,02 USD
Máx. histórico
608,49
2 días
Split 2:1 del 23/09/2009
Caída desde máximo
-7,64%
Rango 52 semanas
444,04 – 614,23
Variación hoy
-0,65%
Cierre anterior
565,72
Rango de hoy
559,41 – 569,45
Volumen hoy
454.934
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,96%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,22 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 5 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 22/03/2006 | 32,19 | 33,11 | 32,00 | 32,97 | +2,09% | 3,45% | 1.032.600 |
| 21/03/2006 | 32,29 | 32,90 | 31,74 | 32,29 | +0,91% | 3,59% | 1.753.200 |
| 20/03/2006 | 32,29 | 32,45 | 31,69 | 32,00 | -0,20% | 2,35% | 727.600 |
| 17/03/2006 | 32,13 | 32,20 | 31,38 | 32,07 | +0,22% | 2,55% | 1.479.200 |
| 16/03/2006 | 32,00 | 32,32 | 31,85 | 32,00 | -0,37% | 1,48% | 515.400 |
| 15/03/2006 | 32,10 | 32,36 | 31,87 | 32,12 | -0,14% | 1,53% | 643.600 |
| 14/03/2006 | 31,73 | 32,27 | 31,34 | 32,16 | +1,26% | 2,92% | 574.800 |
| 13/03/2006 | 32,10 | 32,15 | 31,62 | 31,76 | -0,87% | 1,64% | 879.000 |
| 10/03/2006 | 32,10 | 32,37 | 31,59 | 32,04 | -0,68% | 2,43% | 666.400 |
| 09/03/2006 | 32,32 | 32,48 | 32,02 | 32,26 | -0,29% | 1,44% | 806.200 |
| 08/03/2006 | 32,04 | 32,45 | 31,77 | 32,36 | +0,78% | 2,12% | 992.000 |
| 07/03/2006 | 31,50 | 32,37 | 31,24 | 32,11 | +0,50% | 3,59% | 1.639.400 |
| 06/03/2006 | 31,75 | 32,10 | 31,49 | 31,95 | +0,39% | 1,92% | 897.000 |
| 03/03/2006 | 31,66 | 32,31 | 31,35 | 31,82 | -0,39% | 3,03% | 799.600 |
| 02/03/2006 | 31,19 | 32,04 | 30,73 | 31,95 | +1,62% | 4,18% | 1.367.800 |
| 01/03/2006 | 31,02 | 31,60 | 30,58 | 31,44 | +2,00% | 3,29% | 1.886.600 |
| 28/02/2006 | 31,57 | 31,57 | 30,52 | 30,82 | -2,51% | 3,34% | 1.541.000 |
| 27/02/2006 | 30,80 | 31,73 | 30,75 | 31,62 | +2,48% | 3,17% | 1.328.400 |
| 24/02/2006 | 31,39 | 31,45 | 30,76 | 30,85 | -1,63% | 2,20% | 1.117.200 |
| 23/02/2006 | 30,87 | 31,40 | 30,53 | 31,36 | +1,37% | 2,83% | 1.712.400 |
| 22/02/2006 | 30,74 | 31,43 | 30,71 | 30,94 | +0,49% | 2,33% | 2.486.800 |
| 21/02/2006 | 32,57 | 32,64 | 30,51 | 30,79 | -8,13% | 6,56% | 11.410.800 |
| 17/02/2006 | 34,09 | 34,09 | 32,93 | 33,51 | -1,48% | 3,40% | 1.032.800 |
| 16/02/2006 | 33,24 | 34,07 | 32,95 | 34,02 | +2,12% | 3,37% | 952.400 |
| 15/02/2006 | 32,90 | 33,62 | 32,76 | 33,31 | +1,66% | 2,61% | 407.400 |
| 14/02/2006 | 32,91 | 32,93 | 32,45 | 32,77 | +0,17% | 1,46% | 459.200 |
| 13/02/2006 | 33,02 | 33,25 | 32,39 | 32,71 | -1,90% | 2,60% | 797.800 |
| 10/02/2006 | 33,08 | 33,40 | 32,64 | 33,35 | +1,18% | 2,31% | 727.000 |
| 09/02/2006 | 32,77 | 33,35 | 32,68 | 32,96 | +0,49% | 2,04% | 578.000 |
| 08/02/2006 | 32,89 | 33,27 | 32,54 | 32,80 | -0,55% | 2,23% | 571.400 |